The delisting risk is removed, which is a positive near-term catalyst. However, the company's cash runway is limited (through September 2026 per prior filings) and going-concern doubts persist. Monitor for further capital raises or business updates that could impact the stock's ability to maintain the $1.00 bid price.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 29 $1.69entry
- T+1 · 5mo ago −5.92%α −6.70% · $1.59
- T+5 · 4mo ago −15.98%α −17.36% · $1.42
- T+20 · 4mo ago −16.86%α −16.58% · $1.41
- T+60 · 8w ago −58.80%α −63.19% · $0.6962
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Outlook Therapeutics received a letter from Nasdaq on June 26, 2026, confirming that it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after its common stock closed at $1.00 or above for ten consecutive business days from June 11 to June 25, 2026. This resolves the delisting notice received on February 18, 2026, and the matter is now closed, removing a significant overhang on the stock.
Key Facts
- Nasdaq confirmed compliance with minimum bid price rule on June 26, 2026
- Stock closed at or above $1.00 for ten consecutive business days (June 11–25, 2026)
- Delisting matter is now closed
- Previously notified of non-compliance on February 18, 2026
Financial Impact
No financial figures provided in this filing. The removal of delisting risk may improve liquidity and institutional ownership prospects.
Risk Factors
- Company still faces substantial doubt about its ability to continue as a going concern
- Cash runway only expected into September 2026 based on prior filings
- Potential need for additional dilutive financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-078337 |
| Document: 0001104659-26-078337-index-headers.html | 0001104659-26-078337 |
| Document: 0001104659-26-078337-index.html | 0001104659-26-078337 |
| Document: 0001104659-26-078337.txt | 0001104659-26-078337 |
Track record
37 reports on OTLK
13 of 22 bullish or bearish reports moved the stock their way by T+5. Best: +306.25% at T+20 after the May 26, 2026 report. 18 of 22 went positive at some point.
Filters
- Oct 13, 20264w ago SC 13G Neutral 4/10 Entry $0.5638 to $0.5200 Now $0.3960 −29.76% ▼ −7.77% −6.62% vs SPY
- Oct 6, 20265w ago Press Release Neutral 3/10 Entry $0.5720 to $0.5638 Now $0.3960 −30.77% ▼ −1.43% −1.29% vs SPY
- Sep 18, 20268w ago 8-K Neutral 3/10 Entry $0.6863 to $0.6211 Now $0.3960 −42.30% ▼ −9.50% −8.48% vs SPY
- Aug 14, 202613w ago 8-K Bearish 6/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
- Aug 14, 202613w ago 424B5 Bearish 7/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
- Aug 14, 202613w ago 8-K Bearish 6/10 No price data
- Aug 14, 202613w ago Press Release Mixed 7/10 Entry $0.7564 to $0.6472 Now $0.3960 −47.65% ▼ −14.44% −13.07% vs SPY
- Aug 12, 202613w ago Press Release Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
- Aug 12, 202613w ago 8-K Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
- Jul 24, 202616w ago 8-K Bullish 8/10 Entry $1.07 to $0.9766 Now $0.3960 −62.82% ▼ −8.30% −9.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers